Dyadic International (DYAI) Operating Margin (QoQ) (2018 - 2026)
Powered by 
Analysis
Dyadic International (DYAI) Operating Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn |
| 10 | Dyadic International | 18.44 Mn | 10.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 10,032.00 |
| Dec 31, 2025 | -10,627.00 |
| Sep 30, 2025 | 1,355.00 |
| Jun 30, 2025 | 32,992.00 |
| Mar 31, 2025 | -32,160.00 |
| Dec 31, 2024 | -17,684.00 |
| Sep 30, 2024 | 51,896.00 |
| Jun 30, 2024 | 10,591.00 |
| Mar 31, 2024 | -31,933.00 |
| Dec 31, 2023 | 11,732.00 |
| Sep 30, 2023 | -15,962.00 |
| Jun 30, 2023 | -6,394.00 |
| Mar 31, 2023 | 9,148.00 |
| Dec 31, 2022 | -8,927.00 |
| Sep 30, 2022 | 29,198.00 |
| Jun 30, 2022 | -8,056.00 |
| Mar 31, 2022 | 92,238.00 |
| Dec 31, 2021 | -86,595.00 |
| Sep 30, 2021 | -6,704.00 |
| Jun 30, 2021 | 30,839.00 |